TABLE 1.
Fox genes | Expression | Target genes/pathway | Effects on osteogenesis | Cells/animal model | Reference |
---|---|---|---|---|---|
FoxO1 | Increased | Runx2, ALP, OCN | Promoted | C3H10T1/2 cells | Teixeira et al. (2010) |
FoxO1 | Increased | miR-424/FGF2, Runx2 | Promoted | BMSCs | Li et al. (2017) |
FoxO1/3/4 | Deleted | PPARγ, Runx2, Osx, p66shc | Inhibited | Deletion of FoxO1/3/4 mice | Ambrogini et al. (2010) |
FoxO1/3/4 | Deleted | Wnt/β-catenin, cyclin D1 | Promoted | Bipotential progenitors of osteoblast and adipocytes | Iyer et al. (2013) |
FoxO3a | Increased | ALP, OCN, Runx2, LRP5, LRP6 | Promoted | BMSCs | Sun et al. (2018) |
FoxO3a | Increased | OCN, Runx2 | Inhibited | MC3T3-E1 cells | Tang et al. (2019) |
FoxC1 | Decreased | Msx2, Runx2, ALP | Inhibited | C2C12 cells | Hopkins et al. (2016) |
Decreased | Runx2, osterix | Promoted | MC3T3 cells | Hopkins et al. (2016) | |
FoxC1 | Increased | Msx2, Runx2, ALP | Promoted | C2C12 cells | Mirzayans et al. (2012) |
FoxC1 | KD | Msx2, ALP, OCN, Runx2 | Promoted | O9-1 cells | Sun et al. (2013) |
FoxC2 | Increased | ALP, OCN, Cbfα1, Wnt/β-catenin, BSP, PPARγ2 | Promoted | BMSCs | (Lin et al., 2016) |
FoxP1 | OE | Recombination signal-binding protein, ALP | Promoted | C3H10T1/2 cells | Li et al. (2017) |
KO | ALP, COL1A1, PPARG, CEBPA, FABP4 | Inhibited | BMSCs | Li et al. (2017) | |
FoxP1/2/4 | Decreased | Runx2 | Promoted | Skeletal progenitor cells | Zhao et al. (2015) |
FoxA2 | KD | ERK, ALP, OPN, OCN, Runx2, Col1a1 | Promoted | BMMSCs | Ye et al. (2018) |
FoxD3 | OE | OSX, TNAP, SOX9, OPN | Promoted | hESCs | Kamaldinov et al. (2018) |
FoxD3 | Increased | Wnt/β-catenin | Inhibited | BMMSCs | Huang and Chen, (2017) |
FoxF1 | KD | Wnt/β-catenin | Promoted | BMSCs | Shen et al. (2020) |
FoxF1 | Increased | TGF/β-catenin | Promoted | BMSCs | (Weng et al., 2019) |
FoxM1 | Decreased | RANKL/OPG, ALP | Promoted | PDLCs | Li et al. (2019) |
FoxQ1 | Increased | Wnt/β-catenin, ANXA2, ALP, OCN, OPG, Runx2 | Promoted | BMSCs | Xiang et al. (2020) |
FoxI1 | Deleted | Fgf8 | Inhibited | Foxi1 mutant embryo | Nissen et al. (2003) |
FoxI3 | Deleted | Pax8, Fgf3 | Inhibited | Foxi3 mutant Mice | Edlund et al. (2014) |
FoxL2 | Deleted | GH/IGF1, SOX9 | Inhibited | FoxL2−/− mice | Marongiu et al. (2015) |
FoxG1 | Decreased | Osteocalcin, ALP | Inhibited | Osteoblasts | Uchida et al. (2018) |
Note. OE, overexpression; KD, knock down; BMSCs, bone marrow mesenchymal stem cells; BMMSCs, bone marrow‐derived mesenchymal stem cells; PDLCs, periodontal ligament cells; hESCs, human embryonic stem cells; ALP, alkaline phosphatase; Runx2, Runt-related transcription factor 2; OCL, osteocalcin; PPARγ, proliferator-activated receptor γ2; msx2, msh homeobox 2; ERK, extracellular-regulated protein kinases; RANKL, receptor activator of nuclear factor-κB ligand.